GS
EIGR

George Soros’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

George Soros’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-267
Closed -$2.27M – 293
2015
Q1 		$2.27M Buy
+267
New +$2.33M 0.02% 187

Other funds holding EIGR

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

George Soros's EIGR Position: Q2 2015 in Review

George Soros sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2015, closing a stake of 267 shares — an estimated $2.27M sold.

George Soros first reported a position in EIGR in Q1 2015 and held it in 1 quarter. The position peaked at $2.27M in Q1 2015. 44 funds tracked by Wall St. Rank hold EIGR as of Q2 2015.

  • George Soros reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • George Soros sold 267 Eiger BioPharmaceuticals, Inc. shares in Q2 2015, an estimated $2.27M.
  • George Soros first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • George Soros's Eiger BioPharmaceuticals, Inc. position peaked at $2.27M in Q1 2015.
  • 44 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2015.

Based on Soros Fund Management's 13F filing for Q2 2015, filed 14 Aug 2015.